TrialThe British journal of dermatology2022

Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.

Blake W Boudreaux et al.PubMed ↗Publisher ↗

No numbers read from the abstract.